What we do
We distribute two families of products: Wharton's jelly tissue allografts, sourced from the umbilical cord matrix, and extracellular vesicle (exosome) products derived from cord blood and umbilical tissue. Across both families we distribute eight catalog items, each with its own format, concentration, and documentation.
As a distributor, we are not the manufacturer of these products. Our role is to maintain the chain of custody from the supplier to your practice, keep lot-level documentation available, and give your team a straightforward way to evaluate what you are buying before you order.
FDA states that there are no FDA-approved exosome products. They are generally regulated as biologic drugs under section 351. Purchase and clinical-use decisions for these products belong to the physician, working with their own regulatory counsel.
Who we serve
We sell only to licensed clinics, physician-supervised medspas, and physicians. We do not sell to patients and we do not market to patients. Every account is verified using an NPI number before pricing or documentation is released.
Our process is the same regardless of practice type: verify the account, share the documentation on file, and let the clinic and its own counsel decide how a product fits their practice.
How we work
Cryopreserved products move through a cold chain to your door; lyophilized products ship shelf-stable. Every lot carries a unique identifier so use can be tracked on your side at the patient record level.
If it is useful, we can set up a direct, physician-level conversation about a product's documentation. That conversation covers sourcing and documentation only; clinical decisions remain yours and your counsel's.
These products are not FDA approved or licensed for any disease or condition. Information here is for licensed healthcare professionals and is not medical or legal advice.